Citigroup Issues Pessimistic Forecast for Integer (NYSE:ITGR) Stock Price

Integer (NYSE:ITGR) had its price objective lowered by investment analysts at Citigroup from $92.00 to $89.00 in a research report issued to clients and investors on Friday,Benzinga reports. The firm currently has a “neutral” rating on the medical equipment provider’s stock. Citigroup’s price objective indicates a potential upside of 6.44% from the stock’s previous close.

Other research analysts also recently issued research reports about the company. Wells Fargo & Company raised their price target on Integer from $72.00 to $84.00 and gave the stock an “equal weight” rating in a research note on Friday, February 20th. Wall Street Zen downgraded Integer from a “buy” rating to a “hold” rating in a research note on Sunday, January 25th. Weiss Ratings upgraded Integer from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Tuesday, February 24th. Truist Financial lifted their target price on Integer from $95.00 to $97.00 and gave the company a “buy” rating in a research note on Friday, February 20th. Finally, Raymond James Financial reiterated an “outperform” rating and issued a $101.00 target price on shares of Integer in a research note on Monday, February 23rd. Four equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $98.29.

Integer Stock Down 5.5%

Shares of ITGR traded down $4.89 during mid-day trading on Friday, reaching $83.62. The company’s stock had a trading volume of 602,713 shares, compared to its average volume of 740,517. The company’s 50 day moving average is $86.07 and its 200 day moving average is $81.76. The stock has a market cap of $2.85 billion, a PE ratio of 29.04, a price-to-earnings-growth ratio of 1.42 and a beta of 0.71. The company has a debt-to-equity ratio of 0.69, a current ratio of 3.32 and a quick ratio of 2.23. Integer has a 12-month low of $62.00 and a 12-month high of $126.86.

Integer (NYSE:ITGR) last released its quarterly earnings results on Thursday, April 30th. The medical equipment provider reported $1.20 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.21 by ($0.01). The firm had revenue of $439.58 million for the quarter, compared to analysts’ expectations of $426.48 million. Integer had a return on equity of 13.26% and a net margin of 5.55%.The company’s quarterly revenue was up .5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.31 EPS. Integer has set its FY 2026 guidance at 5.830-6.400 EPS. Equities analysts anticipate that Integer will post 6.47 EPS for the current fiscal year.

Insider Buying and Selling at Integer

In other news, VP Tommy P. Thomas sold 825 shares of the business’s stock in a transaction on Friday, March 13th. The stock was sold at an average price of $85.00, for a total value of $70,125.00. Following the completion of the transaction, the vice president directly owned 4,381 shares of the company’s stock, valued at $372,385. The trade was a 15.85% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 1.10% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Integer

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Sequoia Financial Advisors LLC purchased a new stake in shares of Integer in the first quarter valued at $267,000. ARGA Investment Management LP purchased a new stake in shares of Integer in the first quarter valued at $1,209,000. Kestra Advisory Services LLC grew its position in shares of Integer by 6.2% in the first quarter. Kestra Advisory Services LLC now owns 22,755 shares of the medical equipment provider’s stock valued at $2,002,000 after purchasing an additional 1,331 shares during the period. Azzad Asset Management Inc. ADV grew its position in shares of Integer by 2.5% in the first quarter. Azzad Asset Management Inc. ADV now owns 15,211 shares of the medical equipment provider’s stock valued at $1,339,000 after purchasing an additional 378 shares during the period. Finally, Louisiana State Employees Retirement System purchased a new stake in shares of Integer in the first quarter valued at $1,364,000. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Integer News Roundup

Here are the key news stories impacting Integer this week:

• Positive Sentiment: Revenue and organic growth beat expectations — Q1 sales were roughly $440M (up 0.5% year-over-year) with 1.3% organic growth, driven by strength across key product lines. This topline beat is supporting optimism on demand recovery. ITGR Stock Up Despite Q1 Earnings Missing Estimates, Revenues Rise Y/Y
• Neutral Sentiment: Board has initiated a strategic review to “maximize stockholder value” (including possible sale, merger or other combinations). A review can unlock value but also creates execution and process uncertainty; outcomes are binary and timing is unclear. Integer Announces Strategic Review to Maximize Stockholder Value
• Neutral Sentiment: Company published the full Q1 release, slide deck and held its earnings call (transcript and presentation available). These materials provide detail on segment trends and margin drivers for investors doing deeper diligence. Integer Holdings Corporation 2026 Q1 – Results – Earnings Call Presentation
• Neutral Sentiment: Trading was temporarily halted pre-market on the day of the release for “news pending,” which typically increases short-term volume and volatility once resumed. Integer Announces Strategic Review to Maximize Stockholder Value
• Negative Sentiment: EPS missed consensus by a penny — reported $1.20 vs. $1.21 expected — and year-over-year EPS declined from $1.31, reflecting margin pressure that investors are watching closely. Integer (ITGR) Q1 Earnings Lag Estimates
• Negative Sentiment: FY 2026 EPS guidance was set to $5.83–$6.40, below the consensus (~$6.49), which raises investor concern about margin recovery and near-term earnings growth — a key reason for today’s downside pressure. Integer Q1 2026 Press Release / Guidance

Integer Company Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.